Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 114,610 | 105,555 | 113,420 | 103,379 | 92,999 |
| Cost of Goods | 28,747 | 31,280 | 27,364 | 24,027 | 21,053 |
| Gross Profit | 85,863 | 74,275 | 86,056 | 79,352 | 71,946 |
| Operating Expenses | 52,362 | 52,806 | 40,691 | 28,772 | 23,865 |
| Operating Income | 34,248 | 21,749 | 45,729 | 50,607 | 48,134 |
| Other Income | 1,873 | 1,458 | 473 | 263 | 120 |
| Pre-tax Income | 36,121 | 23,207 | 46,202 | 50,870 | 48,254 |
| Income Tax | 8,928 | 4,485 | 14,386 | 18,323 | 17,496 |
| Net Income Continuous | 27,193 | 18,722 | 31,816 | 32,547 | 30,758 |
| Net Income | $27,193 | $18,722 | $31,816 | $32,547 | $30,758 |
| EPS Basic Total Ops | 1.93 | 1.30 | 2.18 | 2.22 | 2.06 |
| EPS Basic Continuous Ops | 1.93 | 1.30 | 2.18 | 2.22 | 2.06 |
| EPS Diluted Total Ops | 1.89 | 1.27 | 2.11 | 2.15 | 2.01 |
| EPS Diluted Continuous Ops | 1.89 | 1.27 | 2.11 | 2.15 | 2.01 |
| EPS Diluted Before Non-Recurring Items | 2.05 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $40,239 | $27,288 | $50,019 | $54,341 | $51,909 |